CoA Therapeutics

0 followers


CoA Therapeutics was founded in 2018 with the aim of harnessing advances in understanding of the CoA pathway to develop novel therapies for difficult to treat and rare genetic disorders.

Industries

Headquarters

Employees

Links

Org chart

Christine Siu
Chief Operating Officer

Christine Siu

Collapse
Uma Sinha
Chief Scientific Officer
Anna Wade
VP, BD & Operations
Agnieszka Jurecka
VP, Clinical Development
Tessa Forbes
Director, Clinical Operations
Neil Kumar
Director
Jennifer Pavillard
Head Of Regulatory Affairs
Mallory E. Harden
Senior Director | BD And Operations